NSC identifier: |
NSC 743430
|
Compound name: |
2-{4-[4-(4-{4-[6-(4-methyl piperazino)-1H-benzo[d]imidazole-2-yl]phenoxy}butyl)piperazino]butyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione |
CRmiRSNP:
~ Export ~
|
Records:1
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
NSC 743430 |
rs1010169 |
0.04768328 |
M2 |
SYNGR1 |
0.009 |
Target_3'utr |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:1 Current:1
[First] [Prev] [Next] [Last] 
|
SNP:
~ Export ~
|
Records:null
Compound |
SNP |
Significance |
OR value |
Model |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:46
Expression pattern: Sensitivity / Resistance
Total:4 Current:1
[First] [Prev]  Next Last 
|
Gene:
~ Export ~
|
Records:1790
Compound |
Gene |
Significance |
Expression pattern |
NSC 743430 |
LIX1L |
0.002 |
Down Regulated |
NSC 743430 |
EPHA10 |
0.002 |
Up Regulated |
NSC 743430 |
ASPDH |
0.002 |
Up Regulated |
NSC 743430 |
DCK |
0.003 |
Up Regulated |
NSC 743430 |
HOXB5 |
0.003 |
Up Regulated |
NSC 743430 |
HOXB7 |
0.003 |
Up Regulated |
NSC 743430 |
AFF3 |
0.003 |
Down Regulated |
NSC 743430 |
MAN2B1 |
0.003 |
Down Regulated |
NSC 743430 |
NAGLU |
0.003 |
Down Regulated |
NSC 743430 |
NEU1 |
0.003 |
Down Regulated |
NSC 743430 |
PRKAB1 |
0.003 |
Up Regulated |
NSC 743430 |
MAPK9 |
0.003 |
Up Regulated |
NSC 743430 |
UBE2D2 |
0.003 |
Up Regulated |
NSC 743430 |
USP5 |
0.003 |
Up Regulated |
NSC 743430 |
GDA |
0.003 |
Up Regulated |
Expression pattern: Sensitivity / Resistance
Total:120 Current:9
First Prev Next Last 
|